Background--Diabetes is associated with coronary arteriolar endothelial dysfunction. We investigated the role of the small/ intermediate (SK Ca /IK Ca ) conductance of calcium-activated potassium channels in diabetes-related endothelial dysfunction.
C ardiovascular disease is more prevalent in diabetic patients than nondiabetic patients, and is more often extensive and more rapidly progressive. 1 Diabetes is associated with impairment in arterial and arteriolar endothelial function and vasomotor control as well as with increased morbidity and mortality in the patients with coronary artery diseases. [2] [3] [4] Thus, maintaining coronary-arteriolar endothelial function can reduce the incidence of morbidity and mortality of diabetic patients. The mechanism behind the alteration in endothelial dysfunction in diabetic coronary microvasculature is incompletely understood, but may involve dysregulation of electrical signaling in the coronary arteriolar endothelium. [5] [6] [7] [8] This electrical signaling is mediated by small (SK Ca ) and intermediate (IK Ca ) conductance of calcium-activated potassium channels, which are largely responsible for coronary arteriolar relaxation mediated by endothelium-dependent hyperpolarizing factors. 9 ,10 Interestingly, we recently found that the SK Ca /IK Ca channels are predominately present in the human coronary arteriolar endothelium, and inactivation of SK Ca /IK Ca may contribute to the ischemia/reperfusion (I/R) induced endothelial dysfunction in the human coronary arterioles of patients during cardiac surgery. 11, 12 However, few have studied the alterations of SK Ca /IK Ca activity and channel currents/densities, protein expression, and localization in the human coronary endothelium and vasculature in the setting of diabetes. Thus, the goal of this study is to elucidate the role of SK Ca /IK Ca in coronaryarteriolar endothelium dysfunction of diabetic patients. Our central hypothesis is that diabetes may be associated with alterations in the relaxation response of human coronary arterioles to SK Ca /IK Ca activator and dysregulation of SK Ca / IK Ca protein expression/localization, and reduction of SK Ca / IK Ca channel activity/current density of human coronary endothelial cells. Using isolated atrial/vessel tissues and endothelial cells harvested from diabetic and nondiabetic patients during cardiac surgery, we examined whether diabetes affects SK Ca /IK Ca activator-induced coronary arteriolar relaxation, SK Ca /IK Ca protein expression/distribution as measured by Western blotting and immuno-histochemistry, and studied whether diabetes alters SK Ca /IK Ca channel activity, current density, and SK Ca /IK Ca -mediated endothelium-hyperpolarization.
Methods

Human Subjects and Tissue Harvesting
Samples of discarded-right atrial appendage were harvested from clinically similar patients undergoing coronary artery bypass graft surgery before exposure of the heart to blood cardioplegia and cardiopulmonary bypass. All procedures were approved by the Institutional Review Board of Rhode Island Hospital, Alpert Medical School of Brown University, and informed consent was obtained from all enrolled patients as required by the Institutional Review Board.
Microvessel Reactivity
Coronary arterioles (80-to 150-lm internal diameters) were dissected from harvested right atrial appendage tissue samples during atrial cannulation before the onset of cardiopulmonary bypass. Microvessel studies were performed by in vitro organ bath video-microscopy as described previously. 3, 4, 11, 13 After a 60-minute stabilization period in the organ chamber, the microvessels were preconstricted with thromboxane A2 analog U46619 30% to 40% of the baseline diameter. After achievement of this constricted steady state, dose-dependent relaxation was measured in response to the application of the following vasodilators: the activator of intermediate and small conductance K Ca channels (SK Ca /IK Ca ), NS309, or the endothelium-dependent vasodilators ADP and substance P or the endothelium-independent vasodilator sodium nitroprusside. One or 3 interventions were performed on each vessel. The order of drug administration was random. In some cases, endothelial denudation was carried out by advancing a human hair into the lumen and gently abrading the luminal surface. TRAM34 and apamin were also applied for testing the specificity of NS309. The data were acquired and analyzed with p-CLAMP 6.0.4 (Axon Instruments Inc.).
HCAEC Membrane Potential Recording
Perforated whole-cell current-clamps were used to record membrane potentials ( 
Immunoblot
Atrial tissues samples were solubilized in SDS-PAGE buffer. Total protein (40 lg) was fractionated on an 8% to 16% SDS-PAGE and then transferred to a polyvinylidene difluoride membrane (Immobilon-P; Millipore Corporation, Bedford, MA) as previously described. 11, 12 Membranes were incubated for 1 hour at room temperature with 1:200 dilutions of individual rabbit polyclonal primary antibodies to IK Ca , or SK Ca 2.3 (Alomone Labs Ltd, Jerusalem, Israel). The membranes were then incubated for 1 hour with horseradish peroxidaseconjugated secondary anti-Ig, washed 3 times in Tris saline buffer. Peroxidase activity was visualized with enhanced chemiluminescence (Thermo Scientific) and the images were captured with a digital camera system (G Box, Syngene, Cambridge, UK). The Western blot bands were quantified with densitometry using ImageJ software (National Institute of Health, Bethesda, MD). Specificities of the anti-IK-1, and anti-SK2.3 antibodies were demonstrated in the previous studies, respectively.
11,12
Immunofluorescence Photomicroscopy
Atrial tissue sections from 5 patients were deparaffinized in xylene, rehydrated in graded ethanol and PBS solution, and antigen-unmasked with sodium citrate (10 mmol/L, pH=6.0) followed by PBS wash and blocking with 2% BSA in PBS at room temperature for 2 hours. 11, 12 After the PBS wash, overnight incubation with anti-SK2.3 and IK-1 (each used 1:200; Alomone) was performed at 4°C. Anti-mouse, smooth muscle actin (1:1000; Sigma, St. Louis, MO) was used to detect microvascular smooth muscle. Sections were then washed in PBS and incubated with the appropriate Alexa fluor secondary antibody and mounted using fluorescent mounting medium (Vector Labs, Burlingame, CA). Tissue was visualized using a Zeiss LSM510 confocal microscope system (Carl Zeiss MicroImaging, Inc, Thornwood, NY). Tissue labeling with secondary antibody alone or with normal rabbit IgG or serum in place of primary antibody served as a negative control.
Chemicals ADP, substance P, sodium nitroprusside, NS309, TRAM34 and apamin were obtained from Sigma-Aldrich and dissolved in ultrapure distilled water on the day of the study.
Data Analysis
Data are presented as the mean and SEM. Microvessel responses are expressed as percent relaxation of the preconstricted diameter. Microvascular reactivity was analyzed using 2-way repeated-measures ANOVA with a post hoc Bonferroni test. Clinical and Western blot data were analyzed by Kruskal-Wallis tests followed with Dunn multiple comparison test (GraphPad Software, Inc, San Diego, CA). P<0.05 was considered significant.
Results
Patient Characteristics
Patient characteristics are listed in Table. All patients (n=16, 8/group) with preoperative hypertension were on antihypertensive medication (aspirin and/or b-blocker, and/or calcium channel blocker, and/or statins, and/or angiotensin-converting enzyme inhibitors). The preoperative hemoglobin A1C levels were 9.6AE0.3 in diabetic patients and 5.4AE0.12 in nondiabetic patients.
Microvascular Reactivity
There was no significant difference in the baseline diameter of the microvessels among the 2 groups (nondiabetic: 119AE8.5 lm, diabetic: 122AE7.4 lm). The degrees of precontraction by the thromboxane A2 analog U46619 were 33AE3% in the nondiabetic group, and 35AE4% in the diabetic group. The baseline microvascular responses to the endothelium-dependent vasodilators ADP, substance P, and the endothelium-independent vasodilator sodium nitroprusside of arterioles from diabetic patients were significantly decreased as compared to the respective response from nondiabetic patients (P<0.05, Figure 1 ). Importantly, diabetes significantly reduced the arteriolar response to the SK Ca /IK Ca opener NS309 compared to the respective responses of nondiabetic vessels (Figure 2A ). In addition, the relaxation response of diabetic arterioles to NS309 was prevented by denudation of endothelium, suggesting that NS309-induced response is endothelium dependent in the diabetic arterioles ( Figure 2B ).
Effects of Diabetes on SK Ca /IK Ca Channel Currents
Using the primary-cultured HCAECs (passage 4) harvested from diabetic and nondiabetic patients, we have successfully recorded SK Ca /IK Ca currents in the HCAECs by whole cell patch-clamp ( Figures 3 and 4 , n=4/group). In the nondiabetic endothelial cells, the whole cell K + currents at base level (control) were significantly inhibited by addition of the selective IK Ca blocker TRAM34 (10 lmol/L). Inclusion of the selective SK Ca blocker apamin (100 nmol/L) further reduces the whole cell K + currents ( Figure 3A , 3B and 3C). In contrast, diabetes significantly reduced TRAM34-sensitive and apaminsensitive K + currents (P=0.002, Figure 3D ; and P=0.02 
Effects of Diabetes on HCAEC Membrane Potential
Administration of NS309 induced hyperpolarization of HCAEC in both diabetics and nondiabetics. However, diabetes significantly decreased the amplitude of NS309-induced hyperpolarization of HCAEC compared with nondiabetes (P<0.05, Figure 4D ). 
Effect of Diabetes on Levels of SK Ca /IK Ca Polypeptides
There was dramatic decrease in SK2.3 protein levels in the diabetic myocardium, but no statistical significance (P=0.086, Figure 5A and 5B) as compared with nondiabetics. There were slight, but insignificant decreases in IK Ca protein levels in the diabetic myocardium versus nondiabetics (P=0.3, n=5/group, Figure 5A and 5C).
Immunolocalization of Microvessel SK Ca /IK Ca Polypeptides
Immunofluorescent staining of coronary microvessels from diabetic and nondiabetic patients displayed a strong signal in the endothelium (stained in red) for IK Ca -1 and SK Ca 2.3 ( Figure 5D and 5E). IK Ca -1 subunits localized to the microvascular smooth muscle and less abundantly to smooth muscles (stained in green). There were no significant changes in 
Discussion
Diabetes-induced changes in endothelial SK Ca /IK Ca function have been studied in detail in diabetic rodents. [6] [7] [8] For instance, impaired endothelium-dependent hyperpolarizing factors-dilator response has been demonstrated in various vascular beds, particularly in small-sized arteries in different diabetic animal models. The present study further indicates that the dose-dependent/endothelium-dependent relaxation response to the selective SK Ca /IK Ca activator NS309 was significantly decreased in the diabetic coronary arterioles as compared with that of case-matched nondiabetics. This novel finding suggests that diabetes may be associated with downregulation of SK Ca /IK Ca channels in the human coronary microvasculature. SK Ca /IK Ca in endothelial cells modulate vascular diameter through regulation of their membrane potential and blockade of SK Ca /IK Ca channels, causing a significant endothelial membrane potential depolarization. [14] [15] [16] In the animal models, diabetes reduced endothelial SK Ca /IK Ca channel activity and channel current densities and endothelial-dependent hyperpolarization. [6] [7] [8] In the present study, we further investigated the effects of diabetes on SK Ca /IK Ca channel activity/ current densities and membrane potential in human coronary endothelial cells. Our results demonstrate that diabetes is associated with significant reduction of SK Ca /IK Ca channel activity, current densities, and NS309-induced hyperpolarization of human coronary endothelial cells. Clearly, the reduced amount of endothelial SK Ca /IK Ca current density and endothelial hyperpolarization could be responsible for the reduced NS309-induced endothelium-dependent dilation observed in the diabetic vessels.
There are 3 types of K Ca channels: BK Ca , IK Ca , and SK Ca . The BK Ca channels are predominately present in smooth muscle cells, whereas SK Ca /IK Ca channels are found in abundance in endothelial cells. coronary arteriolar endothelial cells. However, diabetes did not alter expression/distribution of SK Ca /IK Ca polypeptides, suggesting that diabetes may induce posttranslational modification (gating or trafficking) of SK Ca /IK Ca channels rather than the steady-state levels of their protein.
There are several limitations of the current study that deserve mention. First, this work should be considered a pilot study, considering the relatively small number of patients and samples. Due to the small sample size/low power, some of the statistical comparisons failed to reach significance. Another limitation is the heterogeneity of the patients; even though they were reasonably well matched, there were differences in medications and the incidence of coexisting illnesses that may affect the findings. This is a limitation of all studies dealing with patients. Third, the effects of insulin therapy might have also contributed to the microvascular function in patients with chronic, poorly controlled diabetes. Finally, due to technical difficulties, we were unable to harvest and culture coronary arteriolar endothelial cells from a small piece of atrial tissue samples. For those experiments shown in Figure 3 and Figure 4 , we instead used human coronary endothelial cells (primary-cultured HCAECs, passage 4), which were derived from large coronary arteries and were typically from donors with or without diabetes.
Obviously, using human coronary arterioles and endothelial cells harvested from nondiabetic and diabetic patients undergoing cardiac surgery provides plenty of advantages over animal conduit arteries and endothelial cells, since the majority of animal diabetic models are performed on young, otherwise healthy animals in the absence of any comorbid illnesses, which on the whole are not adequately representative of the clinical scenario. Thus, the current investigation of SK Ca /IK Ca regulation by using human heart tissues, isolated coronary arterioles, and primary cultured HCAECs is a crucial step between "bench and bedside," although obtaining human heart/vessel tissues and cells is not easy. Obviously, this translational study improves our understanding of the effects of diabetes on endothelial SK Ca /IK Ca channels and may lead to a novel therapy for preserving endothelial function of coronary arteries and arterioles for diabetic patients with coronary heart diseases.
In conclusion, the present study demonstrates that in human coronary arterioles, diabetes inhibits the SK Ca /IK Ca activator-mediated endothelium-dependent relaxation with significant reduction of endothelial SK Ca /IK Ca currents. Inactivation of endothelial SK Ca /IK Ca channels may contribute to coronary endothelial dysfunction in diabetic patients.
